AMRX Chart
- 52-Week Range: $3.12 - $6.02
- Market Capitalization: $1.01B
- Short Percentage: 0%
- Target Price: $6.42
- Shares Outstanding: 150.81M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
AMRX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Amneal Pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 2nd
- Amneal to Report Fourth Quarter and Full Year 2021 Results on March 2, 2022Business Wire | February 4th
- Amneal's $83M Saol Acquisition Deal Expands Its Neurology Presence Into SpasticityBenzinga | January 5th
- Amneal to Virtually Participate at the 40th Annual J.P. Morgan Healthcare ConferenceBusiness Wire | December 21st
- Penny Stocks To Buy Now According To Insiders In December 2021PennyStocks | December 20th
- Amneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 3rd
Company Info
Website: https://www.amneal.com
Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 7,000
Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full time employees: 7,000
$AMRX bounce back baby
$AMRX nearing a decent swing entry point
$AMRX Green today if ya buy
$AMRX I actually want the market pullback 5% is pretty crazy how this market keep going and going
$AMRX overvalued
$AMRX Ride this train. You won't regret.
$AMRX Short again!! 😀 😀